Sign In
Buy GSK
$51.46
-0.0700 (-0.136%)
At Close: Aug 05, 2026
GSK's mRNA flu vaccine programme to proceed to late-stage trials
02:22am, Thursday, 12'th Sep 2024
British drugmaker GSK on Thursday announced positive results from its mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, saying it would now progres
GSK 'clouds' blowing over suggests Berenberg
06:11am, Wednesday, 11'th Sep 2024
GSK PLC (LSE:GSK, NYSE:GSK) has been reiterated as a 'buy' at broker Berenberg, which sees some of the ‘clouds of doubt' that have plagued the pharma group's summer starting to ease. Zantac litigati
GSK herpes vaccine fails in clinical trial
03:25am, Wednesday, 11'th Sep 2024
Shares in GSK PLC (LSE:GSK, NYSE:GSK) fell over 1% after the drug maker said it would abandon further trials for a potential herpes vaccine after disappointing results from its clinical trials so f
GSK's experimental HSV vaccine fails to meet main goal in trial
02:16am, Wednesday, 11'th Sep 2024
British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial and would not be taken forward to a late-stage t
GSK's Respiratory Drug Nucala Meets Goal in COPD Study
10:56am, Monday, 09'th Sep 2024
GSK announces positive data from a phase III study of Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD).
GSK drug promotes ‘significant and clinically meaningful reduction' in asthma symptoms
10:31am, Monday, 09'th Sep 2024
British pharmaceuticals giant GSK PLC (LSE:GSK, NYSE:GSK) has presented late-breaking data at the European Respiratory Society (ERS) International Congress, highlighting a 54% reduction in severe asth
GSK sees positive COPD trial results
03:30am, Friday, 06'th Sep 2024
GSK PLC (LSE:GSK, NYSE:GSK) announced positive results from a Phase III clinical trial, MATINEE, evaluating Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD). The trial met its prim
GSK's asthma drug Nucala meets main goal in smoker's lungs trial
02:17am, Friday, 06'th Sep 2024
British drugmaker GSK on Friday announced positive results from its late-stage trial of asthma drug Nucala in treating chronic obstructive pulmonary disease (COPD), also known as smoker's lungs.
3 GLP-1 Stocks to Buy Now For Big Long-Term Gains
09:12am, Sunday, 01'st Sep 2024
The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive.
Why Is Glaxo (GSK) Up 10.3% Since Last Earnings Report?
12:37pm, Friday, 30'th Aug 2024
Glaxo (GSK) reported earnings 30 days ago. What's next for the stock?
GSK's RSV Vaccine Arexvy Gets EU Nod for Adults Aged 50-59 Years
02:30pm, Thursday, 29'th Aug 2024
The European Commission approves GSK's RSV vaccine, Arexvy, for use in adults aged 50-59 years with increased risk of the disease.
GSK Stock Gains 18.5% Year to Date: Time to Buy, Sell or Hold?
10:15am, Thursday, 29'th Aug 2024
GSK's cheap valuation, reasonable stock price appreciation and bright growth potential indicate that investors should stay invested.
GSK: European Union approves label expansion for RSV jab
03:19am, Thursday, 29'th Aug 2024
The European Commission has approved the expanded use of GSK PLC (LSE:GSK, NYSE:GSK)'s Arexvy, its respiratory syncytial virus (RSV) vaccine, to include adults aged 50 to 59 at increased risk due to u
GSK shares jump on win in Delaware court over ongoing Zantac battle
06:22am, Wednesday, 28'th Aug 2024
GSK shares jumped Wednesday on news Delaware's top court ruled in the pharmaceutical company's favor, by agreeing to review the admissibility of expert evidence that could play a part in the British f
GSK shares higher after Delaware Zantac ruling
03:28am, Wednesday, 28'th Aug 2024
GSK PLC (LSE:GSK, NYSE:GSK) shares opened higher after Delaware's Supreme Court said it will hear an appeal by the UK drug market and other pharmaceutical companies, including Pfizer, Sanofi, and Boeh
